Skip to main content

Table 2 IBS and comorbidity-related costs of health care measured in Norwegian Kroner (NOK) in the six-month follow-up period.

From: How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice

Type of health resource

IBS-related costs

Comorbidity-related costs

p-values *

Consultations

169 (610)

0 (0-5520)

1315 (1915)

539 (0-12688)

P < 0.001

Hospitalisations

710 (6413)

0 (0-58260)

10302 (27330)

0 (0-174780)

P < 0.001

Medications

47 (261)

0 (0-2785)

2999 (6796)

1544 (0-74634)

P < 0.001

Alternative products

26(127)

0 (0-1110)

238(544)

5 (0-4000)

P < 0.001

Total

1049(6574)

0 (0-60468)

14856(30570)

3190 (0-193355)

P < 0.001

  1. * Wilcoxon test due to skewed data.
  2. Results are given both as mean (SD) and median with range (italic). €1 equals NOK 8.